The world is in an immediate need of treatment for coronavirus disease (COVID‐19). Chronic exposure of hydroxychloroquine in the treatment of COVID‐19 may have multiple adverse effects on human physiology, such as cardiac arrhythmias. Natural compounds need to be evaluated as treatment and preventive agents in coronavirus infection. A total of 30 compounds of
Solanum tuberosum
and
Brassica juncea
residue smoke water were selected for the virtual screening against SARS‐CoV‐1, SARS‐CoV‐2 and cellular proteins involved in the mechanism of infection. Docking analysis identified lead molecules with favorable binding energy, number of poses and hydrogen bond interactions, which indicates the effective modulation of ACE2 and TMPRSS2 receptors. Results indicated (a) curcumenol, (b)
N
‐desmethylselegiline, (c) phentermine and (d) sphingolipid derivatives as a selective and potent candidates in comparison to hydroxychloroquine for COVID‐19 treatment. Our
in silico
findings, therefore, warrant further
in vitro
validations of the selected compounds for the discovery of novel preventive and therapeutic drug against SARS‐CoV‐2 infection.
This data article comprises of the total LC-MS QTOF analysis of smoke water prepared from potato and mustard crop residue. LC-MS QTOF analysis revealed a total of 39 compounds from potato crop residue smoke water, whereas mustard crop residue smoke water exhibited 42 compounds. Molecular formula, mass, RT (retention time) and Area are described in the data presented here. Additionally, different database ID of the identified compounds are mentioned in the data table of potato and mustard crop residue smoke water.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.